The 'Make Sense Campaign' for head and neck cancer awareness

Prof René Leemans - General Secretary of the European Head and Neck Society
The 'Make Sense Campaign' for head and neck cancer awareness ( Prof René Leemans - General Secretary of the European Head and Neck Society )
2 Oct 2013

Outcomes of early stage ovarian endometrioid carcinoma

Dr Aalok Kumar - Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada
Outcomes of early stage ovarian endometrioid carcinoma ( Dr Aalok Kumar - Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada )
1 Oct 2013

Aspirin may act on blood platelets to improve survival in colon cancer patients

Dr Marlies Reimers - Leiden University Medical Center, Netherlands
Aspirin may act on blood platelets to improve survival in colon cancer patients ( Dr Marlies Reimers - Leiden University Medical Center, Netherlands )
30 Sep 2013

Comment on primary site tumours from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Comment on primary site tumours from the ECC 2013 Scientific Co-Chair ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
30 Sep 2013

Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian cancer

Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK
Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian cancer ( Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK )
30 Sep 2013

Research shows how aspirin may act on blood platelets to improve survival in colon cancer patients

Dr Marlies Reimers - Leiden University Medical Center, Netherlands
Research shows how aspirin may act on blood platelets to improve survival in colon cancer patients ( Dr Marlies Reimers - Leiden University Medical Center, Netherlands )
30 Sep 2013

Identifying disease-causing mechanisms in cancers with unknown primary site improves treatment and survival

Dr Zoran Gatalica - Caris Life Sciences, Phoenix, USA
Identifying disease-causing mechanisms in cancers with unknown primary site improves treatment and survival ( Dr Zoran Gatalica - Caris Life Sciences, Phoenix, USA )
29 Sep 2013

Prostate-specific antigen test 'does more harm than good'

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Prostate-specific antigen test 'does more harm than good' ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
29 Sep 2013

Results for new antibody drug in non-small cell lung cancer

Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France
Results for new antibody drug in non-small cell lung cancer ( Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France )
29 Sep 2013

Prostate-specific antigen test 'does more harm than good'

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Prostate-specific antigen test 'does more harm than good' ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
29 Sep 2013

Identifying disease-causing mechanisms in cancers with unknown primary site i

Dr Zoran Gatalica - Caris Life Sciences, Phoenix, USA
Identifying disease-causing mechanisms in cancers with unknown primary site i ( Dr Zoran Gatalica - Caris Life Sciences, Phoenix, USA )
29 Sep 2013

Impact of radiotherapy on loco-regional control

Prof Ian Kunkler - University of Edinburgh, UK
Impact of radiotherapy on loco-regional control ( Prof Ian Kunkler - University of Edinburgh, UK )
28 Sep 2013